Conduit Pharmaceuticals

Corvus is the founding and majority shareholder of Conduit Pharmaceuticals, a clinical stage specialty biopharmaceutical company led by highly experienced pharmaceutical executives.

East Imperial Plc

Corvus Capital is pleased to have advised Taylor Partners, the activist shareholder of East Imperial plc (LON: EISB), alongside Strand Hanson, on Taylor Partner's successful proposition to make a number of Board changes at EISB.

Ebers Tech Inc.

Corvus is the founding shareholder of Ebers Tech Inc., a private Canadian pharmaceutical company that utilises Co-crystallization and other technology to generate and monetize unique patented compounds and Intellectual Property around cannabinoids and psychedelics.

Nuformix

Corvus originated and negotiated Nuformix’s successful listing on the London Stock Exchange, by way of a Reverse Takeover by Levrett Plc, delivering 120x return for original investors.

ASOS Plc

Corvus Capital was one of the founding shareholders in ASOS Plc. now the UK’s largest independent online fashion and beauty retailer.

Cloudtag®

Corvus was the founding shareholder & principal provider of capital to AIM listed CloudTag.

Lodore Resources

Corvus was a founding shareholder and structured the initial finance for the flotation of Lodore Resources plc.

Imperial Energy

Corvus was a founding shareholder in Imperial Energy and structured its flotation onto AIM in 2004.